Skip to main content
SpringerLink
Log in

Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Adenosine A1 receptor agonists given prior to myocardial ischemia limit ischemic injury in several species. However, the ability of adenosine receptor agonists to limit infarct size when given at reperfusion has proved controversial. We designed a three-center experimental study using a blinded, randomized treatment protocol to test the hypothesis that adenosine A1 receptor activation during early reperfusion can attenuate lethal reperfusion injury, thereby reducing infarct size. Sixty anesthetized rabbits (20 in each laboratory) underwent 30 minutes coronary artery occlusion followed by 120 minutes reperfusion. The selective adenosine A1 receptor agonist GR79236 (10.5 μg/kg, a dose shown to limit infarction in this model when given before ischemia) or vehicle were administered IV 10 minutes before reperfusion. Infarct size was assessed by tetrazolium staining and, after the randomization code was revealed, data from the three laboratories were pooled for statistical analysis. Infarct size was not modified by administration of GR79236. In the vehicle-treated group, the infarct-to-risk ratio was 28.9 ± 2.7% (n = 24) compared with 31.9 ± 2.6% (n = 26) in the GR79236-treated group (not significant). Risk zone volume was similar in the two groups (1.06 ± 0.05 cm3 vs 1.00 ± 0.05 cm3, respectively). A modest reduction in rate-pressure product was noted following the administration of GR79236, but this effect was transient. The same dose of GR79236 was found to limit infarct size when given prior to coronary artery occlusion. We conclude that A1 receptor activation does not modify lethal reperfusion injury in myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Braunwald E, Kloner RA. Myocardial reperfusion:Adoubleedged sword? J Clin Invest 1985;76:1713-1719.

    PubMed  Google Scholar 

  2. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1985;80:1049-1062.

    Google Scholar 

  3. Yellon DM, Downey JM. Current research views on myocardial reperfusion and reperfusion injury. Cardioscience 1990;1:89-98.

    PubMed  Google Scholar 

  4. Farb A, Kolodgie FD, Jenkins M, Virmani R. Myocardial infarct extension during reperfusion after coronary artery occlusion: Pathologic evidence. J Am Coll Cardiol 1993;21:1245-1253.

    PubMed  Google Scholar 

  5. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-665.

    PubMed  Google Scholar 

  6. Toombs CF, Mc Gee DS, Johnston WE, Vinten-Johansen. Myocardial protective effects of adenosine. Infazet size reduction with pretreatment and continued receptor stimulation during schemia. J. Circulation 1992;86:986-994.

    Google Scholar 

  7. Lasley RD, Rhee JW, Van Wylen DGL, Mentzer RM. Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 1990;22:39-47.

    PubMed  Google Scholar 

  8. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 1987;76:1135-1145.

    PubMed  Google Scholar 

  9. Pitarys CJ, Virmani R, Vildbill HD, Jackson EK, Forman MB. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 1991;83:237-247.

    PubMed  Google Scholar 

  10. Velasco CE, Turner M, Cobb MA, Virmani R, Forman MB. Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: Effect of intracoronary adenosine. Am Heart J 1991;122:1561-1570.

    PubMed  Google Scholar 

  11. Norton ED, Jackson EK, Turner MB, Virmani R, Forman MB. The effects of intravenous infusions of selective adenosine A1 receptor and A2 receptor agonists on myocardial reperfusion injury. Am Heart J 1992;123:332-338.

    PubMed  Google Scholar 

  12. Norton ED, Jackson EK, Virmani R, Forman MB. Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral flow. Am Heart J 1991;122:1283-1291.

    PubMed  Google Scholar 

  13. Homeister JW, Hoff PT, Fletcher DD, Lucchesi BR. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 1990;82:595-608.

    PubMed  Google Scholar 

  14. Goto M, Miura T, Iliodromitis EK, et al. Adenosine infusion during early reperfusion failed to limit infarct size in a collateral deficient species. Cardiovasc Res 1992;25:943-949.

    Google Scholar 

  15. Vander Heide RS, Reimer KA. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 1996;31:711-718.

    PubMed  Google Scholar 

  16. Louttit JB, Hunt AA, Maxwell MP, Drew GM. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemiarepefusion injury in the pig. J Cardiovasc Pharmacol 1999;33:285-291.

    PubMed  Google Scholar 

  17. Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL. Cardioprotective effects of the novel A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998;286:611-618.

    PubMed  Google Scholar 

  18. Gurden MF, Coates J, Ellis F, et al. Functional characterisation of three adenosine receptor types. Br J Pharmacol 1993;109:693-698.

    PubMed  Google Scholar 

  19. Travers A, Middlemeiss D, Louttit JB. Cardioportection after repeated dosing with GR79236, an adenosine A1 receptor agonist. Br J Pharmacol 1998;124 (Proc. Suppl.):102P.

  20. Chien GL, Wolff RA, Davis RF, Van Winkle DM. “Normothermic range” temperature affects myocardial infarct size. Cardiovasc Res 1994;28:1014-1017.

    PubMed  Google Scholar 

  21. Ytrehus K, Liu Y, Tsuchida A, et al. Rat and rabbit heart infarction: Effects of anaesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 1994;267:H2383-H2390.

    PubMed  Google Scholar 

  22. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-746.

    PubMed  Google Scholar 

  23. Schrader J, Baumann G, Gerlach E. Antiadrenergic action of adenosine in the heart: Possible physiological significance. Pflugers Archv 1977;372:29-35.

    Google Scholar 

  24. Richardt G, Waas W, Kranzhomig R, Mayer E, Schomig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: A protective mechanism in early myocardial ischemia. Circ Res 1987;61:117-123.

    PubMed  Google Scholar 

  25. Mainwaring R, Lasley R, Rubio R, Wyatt DA, Mentzer RM. Adenosine stimulates glucose uptake in the isolated rat heart. Surgery 1988;103:445-449.

    PubMed  Google Scholar 

  26. Wyatt DA, Edmunds MC, Rubio R, Berne RM, Lasley RD, Mentzer RM. Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am J Physiol 1989;257:H1952-H1957.

    PubMed  Google Scholar 

  27. Karmazyn M, Cook MA. Adenosine A1 receptor activation attenuates cardiac injury produced by hydrogen peroxide. Circ Res 1992;71:1101-1110.

    PubMed  Google Scholar 

  28. Zhao ZQ, McGee DS, Nakanishi K, et al. Receptor mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 1993;88:709-719.

    PubMed  Google Scholar 

  29. Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vinten-Johansen J. A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 1994;28:270-279.

    PubMed  Google Scholar 

  30. Lee Y-M, Sheu J-R, Yen M-H. BN-063, a newly synthesised adenosine A1 agonist, attenuates myocardial reperfusion injury in rats. Eur J Pharmacol 1995;279:251-256.

    PubMed  Google Scholar 

  31. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: Celluluar sources and sites of actions of adenosine. J Mol Cell Cardiol 1995;27:1041-1054.

    PubMed  Google Scholar 

  32. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1999;34:1711-1720.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Hatter Institute, University College Hospital and Medical School, London, UK

    G.F. Baxter

  2. Heart Institute, Hospital of the Good Samaritan, and University of Southern California, Los Angeles, CA, USA

    S.L. Hale & R.A. Kloner

  3. Department of Physiology, Medical College, University of South Alabama, Mobile, AL, USA

    T. Miki, M.V. Cohen & J.M. Downey

  4. The Hatter Institute, University College Hospital and Medical School, London

    D.M. Yellon

Authors
  1. G.F. Baxter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.L. Hale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Miki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R.A. Kloner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M.V. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J.M. Downey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D.M. Yellon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baxter, G., Hale, S., Miki, T. et al. Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study. Cardiovasc Drugs Ther 14, 607–614 (2000). https://doi.org/10.1023/A:1007850527878

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007850527878

Search

Navigation